BCAT1 and metabolic dysfunction-associated steatotic liver disease: After controlling for age, BMI, fibrosis stage, and DM, the two BCAT1 gene probes (226517_at, 225285_at) were significantly upregulated with several histologic markers of advanced disease, including higher fibrosis stage, higher NAFLD activity scores, steatosis, lobular inflammation and ballooning.